BNP Paribas Financial Markets Sells 6,823 Shares of Avanos Medical, Inc. (NYSE:AVNS)

BNP Paribas Financial Markets reduced its stake in shares of Avanos Medical, Inc. (NYSE:AVNS) by 28.8% during the 3rd quarter, Holdings Channel.com reports. The firm owned 16,893 shares of the company’s stock after selling 6,823 shares during the quarter. BNP Paribas Financial Markets’ holdings in Avanos Medical were worth $406,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. The Manufacturers Life Insurance Company grew its stake in shares of Avanos Medical by 3.6% during the second quarter. The Manufacturers Life Insurance Company now owns 17,137 shares of the company’s stock valued at $341,000 after purchasing an additional 590 shares during the last quarter. KBC Group NV grew its stake in shares of Avanos Medical by 63.0% during the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after purchasing an additional 1,095 shares during the last quarter. New York State Teachers Retirement System grew its stake in shares of Avanos Medical by 2.0% during the third quarter. New York State Teachers Retirement System now owns 72,294 shares of the company’s stock valued at $1,737,000 after purchasing an additional 1,388 shares during the last quarter. Foundry Partners LLC grew its stake in shares of Avanos Medical by 1.1% during the third quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock valued at $3,918,000 after purchasing an additional 1,800 shares during the last quarter. Finally, Caxton Associates LP grew its stake in shares of Avanos Medical by 13.6% during the second quarter. Caxton Associates LP now owns 17,035 shares of the company’s stock valued at $339,000 after purchasing an additional 2,034 shares during the last quarter. 95.17% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

Avanos Medical Trading Down 2.5 %

Shares of NYSE AVNS opened at $17.97 on Friday. The company’s 50 day simple moving average is $20.27 and its 200 day simple moving average is $21.43. Avanos Medical, Inc. has a fifty-two week low of $17.39 and a fifty-two week high of $25.36. The firm has a market capitalization of $825.90 million, a P/E ratio of 52.85 and a beta of 0.95. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.